Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
基本信息
- 批准号:10553150
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAfghanistanAir PollutantsAlloysAreaAsiaAsthmaBiological MarkersBreath TestsBronchiolitisCaliforniaCell Culture TechniquesCellsChronic Obstructive Pulmonary DiseaseClinicClinical ResearchDataDevelopmentDevicesDiseaseDisease ManagementDown-RegulationEicosanoidsEngineeringEnrollmentEnvironmental ExposureEnvironmental ScienceEpithelial CellsEpitheliumEquipment and supply inventoriesExhalationExposure toFire - disastersFundingGoalsHealthHealthcareHealthcare SystemsHumanIn VitroInflammatoryIraqLaboratoriesLungLung diseasesMass Spectrum AnalysisMeasuresMediatingMedicineMetalsMethodsMilitary PersonnelMonitorNewly DiagnosedOilsParticulateParticulate MatterPathway interactionsPatientsPhysical condensationPopulationPositioning AttributePreventionRecording of previous eventsResearchResearch PersonnelRespiratory DiseaseRespiratory Signs and SymptomsRiskSamplingSiteSoldierSourceSystemTechnologyTimeTracheobronchialUp-RegulationVeteransactive dutyairway epitheliumasthma preventionasthmaticasthmatic patientbiobankbiomarker discoverybiomarker validationburn pitcohortcombustion productdisease phenotypeepidemiology studyexperimental studyhuman tissueimprovedin vivometabolomicsmobile sensornovelpersonalized medicinepilot testportabilityportable monitoringpulmonary functionresearch clinical testingresearch studyrespiratory healthsensortooltoxicantvolatile organic compound
项目摘要
The goal of this resubmitted application is to define signature exhaled breath volatile organic
compounds (VOCs) in veterans exposed to toxicants and to develop an effective portable exhaled
breath health monitoring system for soldiers at risk of developing respiratory disease. This project
will bring a suite of portable sensors forward into use with the aim of supporting large scale
epidemiological studies in military respiratory health. Specifically, our proposal responds to the
call for research on the causes, treatment and prevention of chronic obstructive pulmonary
disease, including identification and validation of biomarkers and disease phenotypes, as well as
employing personalized medicine approaches in clinical research and disease management.
While environmental triggers have long been recognized as key factors in respiratory disease, it
has been challenging to concurrently measure health metrics and environmental exposures and
associate the two. Also, a technology gap has existed for portable monitoring systems that can
perform these functions simultaneously while continuously logging data. Breath testing of exhaled
VOC biomarkers is a new concept that has the potential to transform healthcare for military and
civilian populations in the US. Our overarching hypothesis is that a miniature breath analysis
sensor can measure signatures of exhaled breath VOCs in real-time and correlate this to ambient
field exposures as well as changes in lung function among exposed soldiers. This will allow
doctors and researchers to define field exposures that have adverse effects on respiratory health,
including worsening of asthma and the development of COPD. In aim #1, we propose to define
VOC biomarkers produced by the lung upon exposure to the toxicants. We have developed a
reliable method to measure the exceptionally small amount of VOCs emitted from well-
differentiated tracheobronchial epithelial (TBE) cells in vitro. We will utilize this system to identify
the signature and cellular source of VOCs emitted from TBEs exposed to toxicants and traffic
related air pollutants. These experiments will be performed in primary cells from the lungs of
humans in order to correlate with in vivo studies. In aim#2, we plan to expand our inventory of
portable breath samplers for the clinical studies. In aim #3, we will perform a short-term, one-
week clinical study in 4 cohorts at the VANCHCS and UC Davis sites to define a signature of
breath biomarkers, including eicosanoids, that correlate with the presence of disease, namely
asthma. A total of 100 veteran and civilian subjects will be enrolled over 4 years. Together, data
from our tools will allow military doctors, researchers and others to more fully understand asthma
and other respiratory diseases in exposed field soldiers in ways that has never been possible
before.
此次重新提交的申请的目的是定义特征性呼出气挥发性有机物
化合物(挥发性有机化合物)的退伍军人暴露于有毒物质,并开发一种有效的便携式呼气
针对有患呼吸道疾病风险的士兵的呼吸健康监测系统。这个项目
将推出一套便携式传感器投入使用,旨在支持大规模
军事呼吸系统健康的流行病学研究。具体来说,我们的提案回应了
呼吁对慢性阻塞性肺疾病的病因、治疗和预防进行研究
疾病,包括生物标志物和疾病表型的识别和验证,以及
在临床研究和疾病管理中采用个性化医疗方法。
虽然环境触发因素长期以来一直被认为是呼吸道疾病的关键因素,但它
同时测量健康指标和环境暴露一直具有挑战性,
将两者联系起来。此外,便携式监控系统也存在技术差距,该系统可以
在连续记录数据的同时执行这些功能。呼气测试
VOC 生物标志物是一个新概念,有潜力改变军事和医疗保健领域
美国的平民。我们的首要假设是微型呼吸分析
传感器可以实时测量呼出气体 VOC 的特征,并将其与环境相关联
野外暴露以及暴露士兵的肺功能变化。这将允许
医生和研究人员定义对呼吸系统健康产生不利影响的现场暴露,
包括哮喘恶化和慢性阻塞性肺病(COPD)的发展。在目标#1中,我们建议定义
肺部接触毒物后产生的 VOC 生物标志物。我们开发了一个
测量井中排放的极少量 VOC 的可靠方法
体外分化的气管支气管上皮(TBE)细胞。我们将利用该系统来识别
暴露于有毒物质和交通的 TBE 释放的 VOC 的特征和细胞来源
相关空气污染物。这些实验将在来自肺的原代细胞中进行
人类以便与体内研究相关联。在目标#2中,我们计划扩大我们的库存
用于临床研究的便携式呼吸采样器。在目标#3中,我们将执行一项短期的、一-
为期一周的临床研究,在 VANCHCS 和加州大学戴维斯分校的 4 个队列中进行,以确定特征
呼吸生物标志物,包括类二十烷酸,与疾病的存在相关,即
哮喘。四年内将总共招募 100 名退伍军人和平民受试者。一起,数据
我们的工具将使军医、研究人员和其他人更全面地了解哮喘
和其他呼吸道疾病在暴露的野战士兵中以前所未有的方式发生
前。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease.
罗氟司特和阿奇霉素治疗慢性阻塞性肺疾病的疗效比较。
- DOI:10.15326/jcopdf.2021.0224
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Lam,Jenny;Tonnu-Mihara,Ivy;Kenyon,NicholasJ;Kuhn,BrooksT
- 通讯作者:Kuhn,BrooksT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richart W Harper其他文献
Richart W Harper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richart W Harper', 18)}}的其他基金
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10015032 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10355416 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7837499 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7370003 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7561050 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
8215722 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7758765 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6933806 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6653908 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6327134 - 财政年份:2001
- 资助金额:
-- - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
-- - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




